Our Insights
Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.
Regenerative medicine including Stem cell and Exosome related products are developed by Biotech Co.. in Taiwan in recent years; But, due to regulation limited, only cosmetic products were approved for...
Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.
Regenerative medicine including Stem cell and Exosome related products are developed by Biotech Co.. in Taiwan in recent years; But, due to regulation limited, only cosmetic products were approved for...
Taiwan Biotech: Commercialization vs. Licensing – Strategic Choices for Global Market Entry
Do Taiwan biotech companies need to commercialize products ? Or just license deal in Phase 2 or 3. How Taiwan biotech companies to commercialize new products in global market? License...
Taiwan Biotech: Commercialization vs. Licensing – Strategic Choices for Global Market Entry
Do Taiwan biotech companies need to commercialize products ? Or just license deal in Phase 2 or 3. How Taiwan biotech companies to commercialize new products in global market? License...
The Dominance of the US in the Global Pharma Market: Insights and Strategic Lessons for Taiwan Biotech
The projected revenue in the Pharmaceuticals market is estimated to reach US$1,155.00bn in 2024. When comparing globally, it is noteworthy that United States is expected to generate the highest revenue...
The Dominance of the US in the Global Pharma Market: Insights and Strategic Lessons for Taiwan Biotech
The projected revenue in the Pharmaceuticals market is estimated to reach US$1,155.00bn in 2024. When comparing globally, it is noteworthy that United States is expected to generate the highest revenue...
BIOSECURE Act: A Challenge for China, An Opportunity for Taiwan Biotech
On September 9, 2024, the House of Representatives passed HR 8333,1 commonly known as the BIOSECURE Act.2 The bill passed 306-81, far exceeding the two thirds vote required to pass.
BIOSECURE Act: A Challenge for China, An Opportunity for Taiwan Biotech
On September 9, 2024, the House of Representatives passed HR 8333,1 commonly known as the BIOSECURE Act.2 The bill passed 306-81, far exceeding the two thirds vote required to pass.
The Transformative Role of AI in Healthcare and Its Untapped Potential in Pharma Commercialization
As we all know AI show strong impact to current and future human life. How about healthcare? Of course, most of Mega pharma already implant AI in value chain of...
The Transformative Role of AI in Healthcare and Its Untapped Potential in Pharma Commercialization
As we all know AI show strong impact to current and future human life. How about healthcare? Of course, most of Mega pharma already implant AI in value chain of...
Taiwan Biotech’s Global Ambition: Building a Team for International Success
The challenge for Taiwan biotech companies entering Global market is international talent , who must have Taiwan base-HQ thinking, global vision, international trade knowledge, expertise of pharmaceutical business development, marketing,...
Taiwan Biotech’s Global Ambition: Building a Team for International Success
The challenge for Taiwan biotech companies entering Global market is international talent , who must have Taiwan base-HQ thinking, global vision, international trade knowledge, expertise of pharmaceutical business development, marketing,...
